Discriminative Spectral Pattern Analysis for Positive Margin Detection of Prostate Cancer Specimens using Light Reflectance Spectroscopy

2018 ◽  
Vol 8 (2) ◽  
pp. 144-154
Author(s):  
Rahilsadat Hosseini ◽  
Henry Chan ◽  
Payal Kapur ◽  
Jeffrey Cadeddu ◽  
Hani Liu ◽  
...  
2016 ◽  
Vol 195 (2) ◽  
pp. 479-484 ◽  
Author(s):  
Monica S.C. Morgan ◽  
Aaron H. Lay ◽  
Xinlong Wang ◽  
Payal Kapur ◽  
Asim Ozayar ◽  
...  

2014 ◽  
Vol 5 (5) ◽  
pp. 1512 ◽  
Author(s):  
Vikrant Sharma ◽  
Ephrem O. Olweny ◽  
Payal Kapur ◽  
Jeffrey A. Cadeddu ◽  
Claus G. Roehrborn ◽  
...  

Biosensors ◽  
2021 ◽  
Vol 11 (5) ◽  
pp. 153
Author(s):  
Georgios Koukouvinos ◽  
Chrysoula-Evangelia Karachaliou ◽  
Ioannis Raptis ◽  
Panagiota Petrou ◽  
Evangelia Livaniou ◽  
...  

Carbendazim is a systemic benzimidazole-type fungicide with broad-spectrum activity against fungi that undermine food products safety and quality. Despite its effectiveness, carbendazim constitutes a major environmental pollutant, being hazardous to both humans and animals. Therefore, fast and reliable determination of carbendazim levels in water, soil, and food samples is of high importance for both food industry and public health. Herein, an optical biosensor based on white light reflectance spectroscopy (WLRS) for fast and sensitive determination of carbendazim in fruit juices is presented. The transducer is a Si/SiO2 chip functionalized with a benzimidazole conjugate, and determination is based on a competitive immunoassay format. Thus, for the assay, a mixture of an in-house developed rabbit polyclonal anti-carbendazim antibody with the standards or samples is pumped over the chip, followed by biotinylated secondary antibody and streptavidin. The WLRS platform allows for real-time monitoring of biomolecular interactions carried out onto the Si/SiO2 chip by transforming the shift in the reflected interference spectrum caused by the immunoreaction to effective biomolecular adlayer thickness. The sensor is able to detect 20 ng/mL of carbendazim in fruit juices with high accuracy and precision (intra- and inter-assay CVs ≤ 6.9% and ≤9.4%, respectively) in less than 30 min, applying a simple sample treatment that alleviates any “matrix-effect” on the assay results and a 60 min preincubation step for improving assay sensitivity. Excellent analytical characteristics and short analysis time along with its small size render the proposed WLRS immunosensor ideal for future on-the-spot determination of carbendazim in food and environmental samples.


Talanta ◽  
2020 ◽  
Vol 214 ◽  
pp. 120854 ◽  
Author(s):  
Eleftheria Stavra ◽  
Panagiota S. Petrou ◽  
Georgios Koukouvinos ◽  
Anastasios Economou ◽  
Dimitris Goustouridis ◽  
...  

2014 ◽  
Author(s):  
Panagiota Petrou ◽  
Georgios Koukouvinos ◽  
Dimitrios Drygiannakis ◽  
Dimitris Goustouridis ◽  
Ioannis Raptis ◽  
...  

2018 ◽  
Vol 260 ◽  
pp. 282-288 ◽  
Author(s):  
Georgios Koukouvinos ◽  
Dimitrios Goustouridis ◽  
Konstantinos Misiakos ◽  
Sotirios Kakabakos ◽  
Ioannis Raptis ◽  
...  

2014 ◽  
Vol 66 (6) ◽  
pp. 1116-1124 ◽  
Author(s):  
Boyd R. Viers ◽  
William R. Sukov ◽  
Matthew T. Gettman ◽  
Laureano J. Rangel ◽  
Eric J. Bergstralh ◽  
...  

2014 ◽  
Vol 32 (4_suppl) ◽  
pp. 234-234
Author(s):  
John L. Gore ◽  
Michael P Porter ◽  
John M. Corman ◽  
Douglas Edward Sutherland ◽  
Zeila Schmidt ◽  
...  

234 Background: Prostate cancer care is susceptible to regional variation in treatment and outcomes. Recent national recommendations have highlighted the harms of prostate cancer treatment including urinary incontinence and impotence. We prospectively evaluated radical prostatectomy (RP) outcomes at participating Washington-state hospitals to identify quality improvement opportunities in RP care. Methods: A local clinician advisory group developed a chart abstraction tool that captures potential quality concerns in RP care. The abstraction tool was implemented at nine regional hospitals with data consolidated for review quarterly. The research team and clinician advisory group were blinded to hospital identities in feedback reports. Data were analyzed as aggregate rates and hospital-specific rates without risk adjustment using descriptive statistics. Results: We identified 461 patients undergoing RP at nine area hospitals from 2011 to 2013. The majority (74%) were robot-assisted minimally invasive RPs, Participating hospitals report as many as 97% or as few as 12% robot-assisted procedures. 26.3% of cases were pathologic non-organ-confined prostate cancer (pT3 or higher); pathologic stage was not further classified beyond "T2" or "T3" in 31% of RPs. Surgical margins were positive in 18% of cases overall; hospital-specific positive margin rates ranged from 12 to 25% among organ-confined cases and 0 to 75% among stage pT3 or higher prostate cancer. Length of stay exceeded three days post-prostatectomy in more than 10% of cases at 4 hospitals including one hospital where 36% of cases had prolonged lengths of stay. Conclusions: We identified several quality improvement opportunities that may improve health outcomes among men undergoing RP for prostate cancer. Positive margin rates were excessive at some hospitals and may represent uncertainty in the surgical approach to higher risk cases. Variation in lengths of stay may represent provider variability in post-prostatectomy clinical care algorithms. Survey of provider practices may inform development of quality improvement initiatives such as clinical pathways that may address the variations in RP care identified.


Sign in / Sign up

Export Citation Format

Share Document